What You Should Know:
SciBase Holding AB, a developer of augmented intelligence-based solutions for skin disorders, has entered into a collaboration agreement with the Skin and Cancer Institute to pilot Nevisense in several of their…
Continue Reading
The RSNA Margulis Award-winning study introduces a game-changing AI-driven tool for pancreatic cancer detection on CT scans. Led by Po-Ting Chen, M.D., and the team, the research showcases the tool’s 90% sensitivity and 93%…
Continue Reading
Dr. Robert Bard, a leader in radiological diagnostics, advocates for 3D Doppler imaging’s role in non-invasive cancer detection, particularly in breast, prostate, and skin cancers. Highlighting its precision and the reduced need for biopsies,…
Continue Reading
Paige, a global leader in digital pathology solutions, has received the FDA’s Breakthrough Device Designation for Paige Lymph Node. This AI application is a pioneering tool for detecting breast cancer metastases in lymph nodes….
Continue Reading
Teri Thomas, CEO and Managing Director at Volpara Health
Breast cancer awareness is essential for early detection, which is critical for improving survival rates and reducing the burden of this disease. October is Breast Cancer…
Continue Reading
Lunit and Leeds Teaching Hospitals NHS Trust are launching the world’s first prospective study of AI-powered breast screening in symptomatic clinics, using Lunit INSIGHT MMG. This innovative initiative aims to improve breast cancer detection,…
Continue Reading
Cancer detection technology startup Adela announced it secured $48 million in funding, bringing its total raise to $108 million. Labcorp joined the round as a new investor alongside existing investors OrbiMed, Decheng Capital, F-Prime Capital,…
Continue Reading
By Shania Kennedy
September 19, 2023 – The diagnostic performance of a commercially available artificial intelligence (AI) algorithm was comparable with that of human readers of mammograms, according to a study published recently in Radiology.
Screening mammograms…
AtlantiCare, a New Jersey healthcare system, has harnessed artificial intelligence (AI) to enhance lung cancer diagnosis and treatment. Through an AI-driven “virtual clinic” provided by Optellum, the system proactively identifies patients with lung nodules,…
Continue Reading
A new pancreatic cancer prediction model, utilizing routine blood markers, may reduce unnecessary biopsies by up to 6%. Researchers have validated this model, which assesses early-stage pancreatic cancer risk, and found it outperforms individual…
Continue Reading
